Aptevo Therapeutics Statistics Share Statistics Aptevo Therapeutics has 3.29M
shares outstanding. The number of shares has increased by 0.1%
in one year.
Shares Outstanding 3.29M Shares Change (YoY) 0.1% Shares Change (QoQ) 0.01% Owned by Institutions (%) 15.37% Shares Floating 3M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 51.7K, so 1.57% of the outstanding
shares have been sold short.
Short Interest 51.7K Short % of Shares Out 1.57% Short % of Float 1.57% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.05 and the forward
PE ratio is -0.01.
Aptevo Therapeutics's PEG ratio is
0.
PE Ratio -0.05 Forward PE -0.01 PS Ratio 0 Forward PS n/a PB Ratio 0.25 P/FCF Ratio -0.05 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aptevo Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.72,
with a Debt / Equity ratio of 0.97.
Current Ratio 1.72 Quick Ratio 1.72 Debt / Equity 0.97 Debt / EBITDA -0.19 Debt / FCF -0.19 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-652.16K Employee Count 37 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 5.77, so Aptevo Therapeutics's
price volatility has been higher than the market average.
Beta 5.77 52-Week Price Change n/a 50-Day Moving Average 2.41 200-Day Moving Average 46.19 Relative Strength Index (RSI) 27.75 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit -352K Operating Income -24.6M Net Income -24.13M EBITDA -23.78M EBIT -24.13M Earnings Per Share (EPS) -1747.68
Full Income Statement Balance Sheet The company has 8.71M in cash and 4.63M in
debt, giving a net cash position of 4.08M.
Cash & Cash Equivalents 8.71M Total Debt 4.63M Net Cash 4.08M Retained Earnings -247.58M Total Assets 15.62M Working Capital 6.19M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -23.79M
and capital expenditures 0, giving a free cash flow of -23.79M.
Operating Cash Flow -23.79M Capital Expenditures n/a Free Cash Flow -23.79M FCF Per Share -1722.8
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields APVO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for APVO.
Price Target $5920 Price Target Difference n/a Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 27, 2025. It was a
backward
split with a ratio of 1:20.
Last Split Date May 27, 2025 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -27.37 Piotroski F-Score 1
